Doliver Advisors, LP Pfizer Inc Transaction History

Doliver Advisors, LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $45,298 - $58,972	1,150 Added 24.04%	5,934 $242,000
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $199,732 - $260,728	4,784 New	4,784 $245,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $440,127 - $521,853	9,459 New	9,459 $496,000
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $675,747 - $1 Million	-16,354 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$39.25 - $50.42 $46,550 - $59,798	1,186 Added 7.82%	16,354 $703,000
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $153,515 - $173,907	4,275 Added 39.25%	15,168 $594,000
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $26,792 - $30,216	800 Added 7.93%	10,893 $395,000
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $51,878 - $65,968	1,550 Added 18.14%	10,093 $372,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $13,271 - $15,570	418 Added 5.14%	8,543 $314,000
Q2 2020 Aug 10, 2020	BUY	$30.12 - $36.54 $22,288 - $27,039	740 Added 10.02%	8,125 $266,000
Q1 2020 Apr 28, 2020	SELL	$27.03 - $38.62 $8,109 - $11,586	-300 Reduced 3.9%	7,385 $283,000
Q4 2019 Jan 27, 2020	SELL	$32.92 - $37.36 $18,632 - $21,145	-566 Reduced 6.86%	7,685 $301,000
Q3 2019 Nov 04, 2019	BUY	$32.49 - $42.13 $69,073 - $89,568	2,126 Added 34.71%	8,251 $301,000
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $10,125 - $11,124	270 Added 4.61%	6,125 $260,000
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $3,923 - $4,473	-102 Reduced 1.71%	5,855 $256,000
Q3 2018 Nov 02, 2018	BUY	$34.47 - $41.81 $205,337 - $249,062	5,957 New	5,957 $263,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Doliver Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Doliver Advisors, LP with notifications on news.